Monatin, Its Stereoisomers and Derivatives
FULL PAPER
6.94–7.30 (m, 7 H, indole and ar), 10.50 (s, 1 H, CHO) ppm. m/z
Acknowledgments
(%): 327 [M+] (100), 183 (10), 119 (50), 86 (30), 84 (45).
We thank MIUR (Italian Ministry for Research and the Univer-
sity) and University of Milano for financial support (programs CO-
FIN 2002 and FIRST 2003); Fondazione Fratelli Confalonieri (Mi-
lano) for a PhD fellowship to G. Busnelli; Damien Kelly, National
University of Ireland, Galway, for contribution to experimental
work.
(2S)-4-[Hydroxy(1-mesitylsulfonyl-1H-indol-3-yl)methyl]-5-oxopyr-
rolidine-1,2-dicarboxylic Acid (19): A 1 m solution of LiHMDS in
THF (7.3 mmol) was added to a solution of 6 (1.48 g, 6.09 mmol)
in dry THF whilst stirring at –78 °C under nitrogen. The reaction
mixture was stirred for 1 h at –78 °C prior to addition of a solution
of 18 (2.2 g, 6.75 mmol) in THF and BF3·Et2O (2.16 mL,
6.75 mmol). The mixture was stirred for 2.5 h at –78 °C, quenched
with saturated NH4Cl, and extracted with diethyl ether. The com-
bined organic phases were dried with Na2SO4, filtered, and the
solvents evaporated in vacuo. Flash chromatography (hexane/ethyl
acetate, 45:55) gave mixture of 19 (0.89 g, 26%). 1H NMR (CDCl3):
δ = 1.51 (s, 18 H, 2Boc), 1.85 (m, 1 H, 4a-H), 1.99 (m, 1 H, 4b-H),
2.31 (s, 3 H, CH3), 2.53 (s, 6 H, two CH3), 3.29 (m, 1 H, 3-H), 3.75
(s, 3 H, OCH3), 4.58 (dd, 1,2J = 9.2, 1 H, 5-H), 4.8 (s, 1 H, OH),
5.05 (d, 1J = 9.2, 1 H, 6-H), 6.95 (s, 2 H, ar), 7.2–7.8 (m, 5 H,
indole) ppm. m/z (%): 571 [M + 1] (5), 470 (3), 465 (10), 328 (15),
209 (10), 183 (18), 143 (40), 119 (100), 91 (100).
[1] R. Vleggaar, L. G. J. Ackerman, P. S. Steyn, J. Chem. Soc., Per-
kin Trans. 1 1992, 3095–3098.
[2] A. Bassoli, G. Borgonovo, G. Busnelli, M. G. B. Drew, G. Mor-
ini, Eur. J. Org. Chem. 2005, 1652–1658.
[3] WO Pat. 2003045914, 2003.
[4] M. Max, Y. G. Shanker, L. Huang, M. Rong, Z. Liu, F. Cam-
pagne, H. Weinstein, S. Damak, R. F. Margolskee, Nature Ge-
netics 2001, 28, 58–63.
[5] J. P. Montmayeur, S. D. Liberles, H. Matsunami, L. B. Buck,
Nature Neuroscience 2001, 4, 492–498.
[6] M. Kitagawa, Y. Kusakabe, H. Miura, Y. Ninomiya, A. Hino,
Biochem. Biophys. Res. Commun. 2001, 283, 236–242.
[7] G. Nelson, M. A. Hoon, J. Chandrashekar, N. J. P. Ryba, C. S.
Zuker, Cell 2001, 106, 381–390.
[8] X. Li, M. Inoue, D. R. Reed, T. Hunque, R. B. Puchalski,
M. G. Tordoff, Y. Ninomiiya, G. K. Beauchamp, A. A. Bach-
manov, Mamm. Genome 2001, 12, 13–16.
[9] E. Sainz, J. N. Korley, J. F. Battey, S. L. Sullivan, J. Neurochem.
2001, 77, 896–903.
[10] S. Damak, M. Rong, K. Yasumatsu, Z. Kokrashvili, V. Varada-
rajan, S. Zou, P. Jiang, Y. Ninomiya, R. F. Margolskee, Science
2003, 301, 850–853.
[11] G. Q. Zhao, Y. Zhang, M. A. Hoon, J. Chandrashekar, I. Er-
lenbach, N. J. Ryba, C. S. Zuker, Cell 2003, 115, 255–266.
[12] H. Xu, L. Staszewski, H. Tang, E. Adler, M. Zoller, X. Li,
PNAS 2004, 101, 14258–14263.
[13] For a rewiev: D. E. Walters, J. Chem. Ed. 1995, 72, 680–683.
[14] R. S. Shallenberger, T. E. Acree, Nature 1967, 216, 480–482.
[15] L. B. Kier, J. Pharm. Sci. 1972, 61, 1394–1397.
[16] M. A. Castiglione Morelli, F. Lelj, F. Naider, M. Tallon, T.
Tancredi, P. A. Temussi, J. Med. Chem. 1990, 33, 514–520.
[17] T. Yamazaki, E. Benedetti, D. Kent, M. Goodman, Angew.
Chem. Int. Ed. Engl. 1994, 33, 1437–1451.
[18] J. M. Tinti, C. Nofre, D. Glaser, Chem. Senses 1996, 21, 747–
762.
[19] A. Bassoli, M. G. B. Drew, C. K. Hattotuwagama, L. Merlini,
G. Morini, G. R. H. Wilden, QSAR 2001, 20, 3–16.
[20] A. Bassoli, L. Merlini, G. Morini, A. Vedani, J. of Chem. Soc.,
Perkin Trans. 2 1998, 1449–1454.
[21] A. Arnoldi, A. Bassoli, G. Borgonovo, M. G. B. Drew, L. Mer-
lini, G. Morini, Journal of Agricultural and Food Chemistry
1998, 46, 4002–4010.
[22] A. Bassoli, M. G. B. Drew, L. Merlini, G. Morini, J. Med.
Chem. 2002, 45, 4402 –4409.
(2S)-4-[Hydroxy(1-mesitylsulfonyl-1H-indol-3-yl)methylene]-5-oxo-
pyrrolidine-1,2-dicarboxylic Acid (20): The aldol mixture 19 (0.70 g,
1.23 mmol) was dissolved in dry CH2Cl2 and treated with methane-
sulphonyl chloride (0.1 mL, 1.35 mmol) and TEA (1.46 mL,
13.5 mmol). After 2 d at room temperature, the reaction mixture
was quenched with water and extracted with CH2Cl2. The organic
layer was dried with Na2SO4, and the solvent evaporated under
reduced pressure. After purification of the crude product by flash
chromatography (hexane/ethyl acetate, 6:4), a white solid product
(0.39 g, 57%) was obtained as a mixture of E/Z isomers. M.p. 85–
88 °C. 1H NMR (CDCl3): δ = 1.55 (s, 18 H, Boc E and Z), 2.27 (s,
3 H, pCH3 Z), 2.3 (s, 3 H, pCH3 E), 2.52 (s, 6 H, OCH3 of E), 2.58
(s, 6 H, OCH3 Z), 2.85–2.9 (m, 2 H, 4a-H E and Z), 3.25–3.32 (m,
2 H, 4b-H E and Z), 3.78 (s, 3 H, OCH3 Z), 3.8 (s, 3 H, OCH3 E),
1
2
1
4.68 (dd, J = 4.5, J = 10.0 Hz, 1 H, 5-H Z), 4.78 (dd, J = 3.5,
2J = 10,0 Hz, 1 H, 5-H E), 6.95 (s, 2 H, ar of Z), 6.97 (s, 2 H, ar
of E), 7.1 (br. t, 1 H, CH=C Z), 7.19–7.31 (m, 8 H, indole Z and
1
E), 7.77 (s, 1 H, 8-H E), 7.78 (s, 1 H, 8-H Z), 7.81 (t, J = 3.0, 1
H, CH=C, E) ppm. m/z (%): 552 [M+] (30), 452 (100), 393 (10),
327 (10), 269 (40), 209 (30), 119 (30), 71 (20). [α]2D5 = +23 (c = 1.0,
CHCl3).
(2S,4S)-4-[Hydroxy(1-mesitylsulfonyl-1H-indol-3-yl)methyl]-5-oxo-
pyrrolidine-1,2-dicarboxylic Acid (21): M.p. 58–60 °C. 1H NMR
(CDCl3): δ = 1.50 (s, 9 H, Boc), 1.72 (m, 1 H, 3a-H),2.30 (s, 3 H,
CH3), 2.52 (s, 6 H, two CH3), 2.43 (m, 1 H, 3b-H), 2.84 (m, 1 H,
1
CH2), 2.95 (m, 1 H, 4-H), 3.40 (dd, 1 H, CH2), 4.50 (dd, J = 9.6,
2J = 11.2, 1 H), 6.97 (s, 2 H), 7.20 (m, 2 H), 7.31 (m, 1 H), 7.4 (s,
1 H), 7.5 (m, 1 H) ppm. m/z (%): 554 [M+] (20), 522 (10), 396 (10),
318 (10), 266 (10), 242 (100) 183 (10). [α]2D5 = +18.2 (c = 1.0,
CHCl3). The absolute configuration was assessed by NMR mono-
and bi-dimensional NOE experiments (Supplementary Information
available).
[23] K. Nakamura, K. Kogiso, T. Nakajima, H. Kayahara, Peptide
Sci. 2004, 40, 61–64.
[24] J. Ezquerra, C. Pedregal, A. Rubio, Y. Yruretagoyena, A. Escri-
bano, S. Sanchez-Ferrando, Tetrahedron 1993, 49, 8665–8678.
[25] J. Ezquerra, C. Pedregal, A. Rubio, Y. Yruretagoyena, J. Org.
Chem. 1995, 60, 2925–2930.
[26] US Patent 5994559, 1999.
[27] A. Arnoldi, A. Bassoli, G. Borgonovo, L. Merlini, G. Morini.,
J. Agric. Food Chem. 1997, 45, 2047–2054.
2-Hydroxy-2-(1H-indol-3-ylmethyl)pentanedioic Acid (23): Lactone
22[26] (71 mg, 0.26 mmol) was stirred in aqueous EtOH and KOH
(0.5 mmol) at room temperature for 2 d. Acidic workup followed
by extraction with ethyl acetate gave compound 23. White solid
(25 mg, 30%). 1H NMR ([D6]acetone): δ = 2.40 (m, 4 H, CH2),
3.45 (m, 2 H, CH2-indole), 7.10–7.70 (m, 5 H, indole), 10.20 (br. s,
1 H, NH) ppm. m/z (%): 287 [M+] (10), 259 (5), 229 (5), 200 (5),
155 (20), 149 (30).
[28] J. J.P Stewart, J. Comput.-Aided Mol. Des. 1990, 4, 1–105.
[29] A. Vedani, P. Zbinden, J. P. Snyder, P. A. Greenidge, J. Am.
Chem. Soc. 1995, 117, 4987–4994.
[30] A. Vedani, D. W Hutha, J. Am. Chem. Soc. 1990, 112, 4759–
4767.
Received: December 28, 2004
Eur. J. Org. Chem. 2005, 2518–2525
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2525